Jonathan Chernoff works with Temple University Health System and Temple University leadership to guide Fox Chase into the future of cancer care. A molecular oncologist and medical oncologist, he helps Fox Chase focus on areas that best leverage the institution’s strengths in scientific development.
Martin Edelman’s research focuses on interdisciplinary and multimodality treatment of lung cancer with the goal of translating laboratory observations into practical clinical trials. His role at Fox Chase is to facilitate interactions between laboratory and clinical investigators.
Carolyn Y. Fang studies how psychosocial and behavioral factors influence cancer risk and outcomes, particularly in underserved populations. Her work has made significant contributions to informing evidence-based approaches for addressing cancer health disparities.
As Associate Director for System Integration, Erica Golemis works with Fox Chase and Temple scientists to develop relationships that will lead Fox Chase into the future. As chair of the Department of Cancer and Cell Biology at the Lewis Katz School of Medicine, she focuses on identifying and supporting research synergies that advance cancer research and cancer care.
John Gricoski is responsible for administration of the center, including oversight of research operating and capital budgets, and laboratory space planning. He also manages the NCI Cancer Center Support Grant. Gricoski has an MBA in finance and is a licensed Pennsylvania CPA.
Camille Ragin’s research focuses on gene-environment interactions and cancer health disparities. Her work applies molecular biomarkers, genomics, and public health tools to cancer research in African American communities and African-descended populations worldwide.
Rall focuses on the intersection of virology, immunology, and neurobiology. As associate director of education and training, Rall oversees all faculty affairs, as well as mentoring and education programs.
As director of the Fels Cancer Institute for Personalized Medicine at Temple, Tomasz Skorski oversees the planning, organization, and direction of the institute’s operations and programs. His lab focuses on determining of the role of DNA repair mechanisms in acute and chronic leukemias.
Margaret von Mehren’s research focuses on developmental therapeutics for sarcomas and gastrointestinal stromal tumors. Her work in this area informs her role as the associate director for clinical research, in which she oversees much of the clinical trials process at Fox Chase.
In his role as scientific director, David Wiest oversees the overall direction of science research at the center. His lab explores the molecular basis for normal and malignant hematopoiesis, with a particular emphasis on T lymphocyte development.
Charnita Zeigler-Johnson works with community partners as well as cancer center leadership and clinical chairs to address the needs of the communities that Fox Chase serves. She also integrates community-engaged research across scientific programs at Fox Chase and Temple Health.
